Anne Mccune
Bristol, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Defining Risk in Alcohol-Associated Liver Disease Using the Model for End-Stage Liver Disease.
Journal: The American journal of gastroenterology
Published: January 14, 2025
Diabetes mellitus in alcohol-associated liver disease: Prevalence and outcomes.
Journal: Hepatology communications
Published: November 14, 2024
Incidence and predictors of non-hepatic cancers in biopsy-proven alcohol-related liver disease.
Journal: Annals of hepatology
Published: August 14, 2024
Extra-hepatic morbidity and mortality in alcohol-related liver disease: Systematic review and meta-analysis.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: November 08, 2022
Inequity in end-of-life care for patients with chronic liver disease in England.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: June 28, 2022
UK-Wide Multicenter Evaluation of Second-line Therapies in Primary Biliary Cholangitis.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: February 03, 2022
Corrigendum to 'Alfapump® system vs. large volume paracentesis for refractory ascites: A multicenter randomized controlled study' [J Hepatol 67 (2017) 940-949].
Journal: Journal of hepatology
Published: October 07, 2019
Palliative care in liver disease: what does good look like?
Journal: Frontline gastroenterology
Published: July 04, 2019
Baseline neutrophil-to-lymphocyte ratio predicts response to corticosteroids and is associated with infection and renal dysfunction in alcoholic hepatitis.
Journal: Alimentary pharmacology & therapeutics
Published: February 18, 2019
Obesity in acute alcoholic hepatitis increases morbidity and mortality.
Journal: EBioMedicine
Published: February 12, 2019
Patients with refractory ascites treated with alfapump® system have better health-related quality of life as compared to those treated with large volume paracentesis: the results of a multicenter randomized controlled study.
Journal: Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation
Published: February 14, 2018
Corrigendum to "Alfapump® system vs. large volume paracentesis for refractory ascites: A multicenter randomized controlled study" [J Hepatol 67 (2017) 940-949].
Journal: Journal of hepatology
Published: February 04, 2018
Last Updated: 09/26/2026